Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06758414 · ClinicalTrials.gov registry record · NA

CBT-CP for Veterans With SMI

A NA study of Schizophrenia and Chronic Pain, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
190
Enrollment target
1
Study location

NCT06758414: Recruiting NA study of Schizophrenia and Chronic Pain, sponsored by VA Office of Research and Development.

NCT06758414 is a NA study of Schizophrenia and Chronic Pain that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 190 participants, below the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (13% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06758414, a NA study of Schizophrenia and Chronic Pain, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
190 participants
Enrollment target
1
Study location

Study Summary

Chronic musculoskeletal pain has a highly negative impact on Veterans, especially those with serious mental illness (SMI). Chronic musculoskeletal pain leads to poorer mental and physical health-related functioning, representing a critical obstacle to rehabilitation and recovery for SMI Veterans. Despite known high prevalence rates of chronic pain in SMI populations, there is little research to evaluate nonpharmacological pain management strategies in this population. This study aims to address this research and clinical gap by testing the efficacy of Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) - a VA evidence-based psychotherapy for chronic pain - in Veterans with SMI and chronic low back pain. The study will primarily evaluate the impact of CBT-CP on pain-related functioning, quality of life, and pain severity. This study will also examine relationships between pain and mental health symptoms, and how these relationships may change with CBT-CP completion.

Primary Outcome

The Brief pain Inventory - Interference subscale (BPI-INT) is a 9-item questionnaire measuring pain-relate interference. Respondents answer the degree to which pain interferes with mood/affect and physical activity on a scale from 0 (not at all) to 10 (all the time/completely). An average score is calculated, with a score of \>= 4 indicating moderate to severe pain interference. The instrument has excellent psychometric properties and is regularly used in pain research and clinical practice.

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy for Chronic Pain (CBT-CP)
  • BEHAVIORAL Health & Wellness (H&W)

Study Locations (1)

Maryland

  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD - Baltimore

Trial Details

FieldValue
Enrollment Target 190 participants
Start Date 2026-02-01
Est. Completion 2029-09-30
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT06758414 shows while recruiting

NCT06758414 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, below the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (13% lower).

The record links to 5 conditions, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) is the first listed.

NCT06758414 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06758414 about?

NCT06758414 is a clinical study titled "CBT-CP for Veterans With SMI". Chronic musculoskeletal pain has a highly negative impact on Veterans, especially those with serious mental illness (SMI). Chronic musculoskeletal pain leads to poorer mental and physical health-related functioning, representing a critical obstacle to rehabilitation and recovery for SMI Veterans. De...

What is the current status of trial NCT06758414?

This trial is currently recruiting. It is a NA study. The enrollment target is 190 participants. The study started on 2026-02-01. Estimated completion is 2029-09-30.

What conditions does trial NCT06758414 study?

This clinical trial studies the following conditions: Schizophrenia, Chronic Pain, Bipolar Disorder, Psychotic Disorders, Affective Disorders, Psychotic.

What interventions are being tested in trial NCT06758414?

The interventions under investigation include: Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) (BEHAVIORAL), Health & Wellness (H&W) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06758414?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06758414 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06758414's enrollment target sits among peer trials

190 91st of 315 higher than 225 of 315 other Schizophrenia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03257033 · 190 participants · Phase 3

    Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

  • NCT03642028 · 190 participants · Phase 4

    Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress

  • NCT04015609 · 190 participants · NA

    Psychotherapy Intervention for Latinos With Advanced Cancer

  • NCT04284397 · 190 participants · Early Phase 1

    Identification of Critical Thermal Environments for Aged Adults

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06758414, the US trial registry maintained by the National Library of Medicine. NCT06758414 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.